# A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

> **NCT07199309** · PHASE2 · RECRUITING · sponsor: **Marea Therapeutics** · enrollment: 30 (estimated)

## Conditions studied

- Hypertriglyceridemia

## Interventions

- **DRUG:** MAR001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07199309
- **Lead sponsor:** Marea Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-26
- **Primary completion:** 2026-07
- **Final completion:** 2026-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07199309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07199309, "A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07199309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*